Related Experiment Video
Updated: Sep 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer
Kamal S Pohar1, Michael C Gong, Robert Bahnson
1Division of Urology, Department of Surgery, Ohio State University College of Medicine and Public Health, 4841 UHC, 456 West 10th Avenue, Columbus, OH 43210, USA. pohar-1@medctr.osu.edu
Abstract:
Prostate cancer has become a major public health issue and the search for etiologic risk factors and the development of chemopreventive agents has gained momentum over the last decade. An important epidemiologic finding has been the association between the consumption of tomato products and a lower risk of prostate cancer. Several investigators have proposed that lycopene, a carotenoid consumed largely from tomato products, may be the component responsible for lowering the risk of prostate cancer. Laboratory and clinical studies have been initiated with the goal of assessing the ability of pure lycopene to serve as a chemopreventive agent for prostate cancer. The focus on lycopene should continue, and an improved understanding of lycopene absorption, distribution, role in antioxidant reactions, and metabolism is critical in the quest to elucidate mechanisms whereby this compound may possibly reduce prostate cancer risk.
Insights
Lycopene, found in tomatoes, may lower prostate cancer risk. Further research into its absorption, antioxidant role, and metabolism is crucial for understanding its chemopreventive potential.
Area of Science:
- Oncology
- Nutritional Science
- Epidemiology
Background:
- Prostate cancer is a significant public health concern.
- Research is actively seeking risk factors and chemopreventive agents.
- Epidemiological studies suggest a link between tomato product consumption and reduced prostate cancer risk.
Purpose of the Study:
- To investigate lycopene as a potential chemopreventive agent for prostate cancer.
- To assess the efficacy of pure lycopene in cancer prevention.
- To deepen the understanding of lycopene's biological mechanisms.
Main Methods:
- Review of laboratory and clinical studies on lycopene.
- Analysis of epidemiological data associating tomato consumption with prostate cancer risk.
- Focus on lycopene's absorption, distribution, antioxidant properties, and metabolism.
Main Results:
- Lycopene, a carotenoid abundant in tomatoes, is hypothesized to be responsible for the observed reduction in prostate cancer risk.
- Preliminary studies suggest lycopene's potential as a chemopreventive agent.
- Further investigation is needed to confirm these findings.
Conclusions:
- Lycopene is a promising candidate for prostate cancer chemoprevention.
- Understanding lycopene's mechanisms of action, including its antioxidant role and metabolism, is critical.
- Continued research is essential to elucidate how lycopene may reduce prostate cancer risk.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Atherosclerosis III: Management
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

